Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of 1H-MRS studies
Christina Wenneberg, Birte Glenthøj, Carsten Hjorthøj, et al.
Schizophrenia Research (2019) Vol. 215, pp. 38-48
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 744-757
Closed Access | Times Cited: 105
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 57
Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
Ajay Sarawagi, Narayan Datt Soni, Anant B. Patel
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 100
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development
Alice Egerton, Anthony A. Grace, James Stone, et al.
Schizophrenia Research (2020) Vol. 223, pp. 59-70
Open Access | Times Cited: 83
Recent trends in carbon-based microelectrodes as electrochemical sensors for neurotransmitter detection: A review
Rui Liu, Zhiyuan Feng, Donghao Li, et al.
TrAC Trends in Analytical Chemistry (2022) Vol. 148, pp. 116541-116541
Closed Access | Times Cited: 51
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk
Valerie J. Sydnor, David R. Roalf
Schizophrenia Research (2020) Vol. 226, pp. 61-69
Open Access | Times Cited: 56
Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders
Jing Xu, Youseff Jakher, Rebecca C. Ahrens‐Nicklas
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7490-7490
Open Access | Times Cited: 52
Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions
David R. Lynch, Garrett Farmer
Neuronal Signaling (2021) Vol. 5, Iss. 2
Open Access | Times Cited: 32
pH Auto-Sustain-Based Fermentation Supports Efficient Gamma-Aminobutyric Acid Production by Lactobacillus brevis CD0817
Mengya Jia, Yisong Zhu, Lingqin Wang, et al.
Fermentation (2022) Vol. 8, Iss. 5, pp. 208-208
Open Access | Times Cited: 26
Dopamine and glutamate in individuals at high risk for psychosis: a meta‐analysis of in vivo imaging findings and their variability compared to controls
Robert A. McCutcheon, Kate Merritt, Oliver Howes
World Psychiatry (2021) Vol. 20, Iss. 3, pp. 405-416
Open Access | Times Cited: 26
Medial Frontal Cortex GABA Concentrations in Psychosis Spectrum and Mood Disorders: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies
Molly Simmonite, Clara J. Steeby, Stephan F. Taylor
Biological Psychiatry (2022) Vol. 93, Iss. 2, pp. 125-136
Open Access | Times Cited: 16
Progressive Changes in Glutamate Concentration in Early Stages of Schizophrenia: A Longitudinal 7-Tesla MRS Study
Peter Jeon, Roberto Limongi, Sabrina D. Ford, et al.
Schizophrenia Bulletin Open (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 27
Reduced GABA/glutamate in the thalamus of individuals at clinical high risk for psychosis
Gonzalo M. Quiñones, Ahmad Mayeli, Victor E. Yushmanov, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 6, pp. 1133-1139
Open Access | Times Cited: 24
Sarcosine as an add-on treatment to antipsychotic medication for people with schizophrenia: a systematic review and meta-analysis of randomized controlled trials
Mattia Marchi, G. Galli, Federica Maria Magarini, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 4, pp. 483-493
Closed Access | Times Cited: 20
The impact of spectral basis set composition on estimated levels of cingulate glutamate and its associations with different personality traits
Verena F. Demler, Elisabeth Sterner, Martin Wilson, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition
Christina Wenneberg, Merete Nordentoft, Egill Rostrup, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2019) Vol. 5, Iss. 6, pp. 569-579
Closed Access | Times Cited: 21
Translational Neuroimaging in Psychiatry
Marcella Bellani, Maria Gloria Rossetti, Eleonora Maggioni, et al.
Cambridge University Press eBooks (2024), pp. 158-176
Closed Access | Times Cited: 1
Faster bi-stable visual switching in psychosis
Kyle W. Killebrew, Hannah R. Moser, Andrea Grant, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
A Review of Potential Neuroimaging Biomarkers of Schizophrenia-Risk
Daniel Mamah
Journal of Psychiatry and Brain Science (2023)
Open Access | Times Cited: 4
MR-Spectroscopy of GABA and Glutamate/Glutamine Concentrations in Auditory Cortex in Clinical High-Risk for Psychosis Individuals
Tineke Grent-’t-Jong, Ruchika Gajwani, Joachim Groß, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 7
Determinants of Schizophrenia Endophenotypes Based on Neuroimaging and Biochemical Parameters
Amira Bryll, Wirginia Krzyściak, Paulina Karcz, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 372-372
Open Access | Times Cited: 9
Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol
Katharina Oravsky Sandström, Olga B. Baltzersen, Anouk Marsman, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 5
Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
Christina Wenneberg, Birte Glenthøj, Louise Birkedal Glenthøj, et al.
European Psychiatry (2020) Vol. 63, Iss. 1
Open Access | Times Cited: 7
Multi-Scale Understanding of NMDA Receptor Function in Schizophrenia
Jo Soo Hyun, Takafumi Inoue, Akiko Hayashi‐Takagi
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1172-1172
Open Access | Times Cited: 6
Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model
Ana Carolina Dutra-Tavares, Alex C. Manhães, Keila A. Semeão, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0257986-e0257986
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top